2016
DOI: 10.3390/mi7070122
|View full text |Cite
|
Sign up to set email alerts
|

High-Throughput Assessment of Drug Cardiac Safety Using a High-Speed Impedance Detection Technology-Based Heart-on-a-Chip

Abstract: Drug cardiac safety assessments play a significant role in drug discovery. Drug-induced cardiotoxicity is one of the main reasons for drug attrition, even when antiarrhythmic drugs can otherwise effectively treat the arrhythmias. Consequently, efficient drug preclinical assessments are needed in the drug industry. However, most drug efficacy assessments are performed based on electrophysiological tests of cardiomyocytes in vitro and cannot effectively provide information on drug-induced dysfunction of cardiomy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 45 publications
(30 citation statements)
references
References 28 publications
0
30
0
Order By: Relevance
“…Zhang et al [84] introduced the heart-on-a-chip device that used high-speed impedance detection to assess cardiac drug efficacy. The device records the contraction of CMs to reveal drug effects.…”
Section: Heart-on-a-chipmentioning
confidence: 99%
“…Zhang et al [84] introduced the heart-on-a-chip device that used high-speed impedance detection to assess cardiac drug efficacy. The device records the contraction of CMs to reveal drug effects.…”
Section: Heart-on-a-chipmentioning
confidence: 99%
“…The free Ca 2+ then binds to troponin and activates myosin attachment to the actin filament, pulling the latter to the center of the sarcomere to complete a mechanical contraction [ 167 ]. Zhang et al assessed this phenomenon in their OoC system [ 168 ] by means of a high-speed impedance detection technology based on a nonconductive substrate with a pattern of 16 interdigitated electrodes (IDEs) to culture primary neonatal rat cardiomyocytes (NRCM) monolayers and to record the rapid impedance fluctuations induced by their beating [ 169 ]. Administration of verapamil, an L-type calcium channel blocker, which reduces calcium influx and action potential duration, resulted in a recorded decrease in the beating rate and contractility of cardiomyocytes, demonstrating the suitability of their heart-on-a-chip to evaluate drug effect.…”
Section: Biosensors For Measuring Ooc’ Electromechanical Activitymentioning
confidence: 99%
“…Contractile properties of cells, especially cardiomyocytes for heart-on-a-chip platforms is of great importance and it is reported to be affected by intracellular calcium secretion. Hence, it is important to measure the calcium levels for heart-on-a-chip platforms (56,57).…”
Section: Sensors To Monitor Cell Behaviormentioning
confidence: 99%